Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$4.3 - $7.78 $1,745 - $3,158
406 Added 2.96%
14,140 $75,000
Q4 2022

Feb 07, 2023

BUY
$5.57 - $11.01 $2,991 - $5,912
537 Added 4.07%
13,734 $86,000
Q3 2022

Nov 07, 2022

BUY
$5.34 - $12.79 $240 - $575
45 Added 0.34%
13,197 $139,000
Q2 2022

Jul 28, 2022

BUY
$5.1 - $9.74 $67,075 - $128,100
13,152 New
13,152 $71,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $110M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.